Skip to main content
Clinical Trials/JPRN-jRCTs062180083
JPRN-jRCTs062180083Completed未知

Research for the development of percutaneous method to detect cytokines in inflammatory skin diseases - Percutaneous approach to detect cytokines in inflammatory skin diseases

Koji Sayama0 sites32 target enrollmentStarted: March 20, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
32

Study Overview

Brief Summary

It could be possible to evaluate the skin damage without skin biopsy by analyzing lesional and non-lesional IFN-gamma levels. However, more cases are required to confirm this results. IFN-gamma or TNF-alpha could be easily detectable in cases with severe skin damage.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 16age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Inflammatory skin diseases presenting erythematous plaque with slight scaling.
  • Such as bullous pemphigoid, prurigo chronica multiformis, erythema nodosum, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, toxicoderma.

Exclusion Criteria

  • 1. History of atopic dermatitis
  • 2. Subjects with systemic infectious diseases
  • 3. Defined history of allergic contact dermatitis from adhesive tapes.
  • 4. Other judged as being inappropriate for the study by the investigators.

Investigators

Sponsor
Koji Sayama

Similar Trials